MJH Hosts Free Webinar on COVID-19 Vaccine Candidates

July 28, 2020
Keith A. Reynolds
Keith A. Reynolds

A trio of experts will discuss the prospects of a handful of COVID-19 vaccine candidates which are entering phase 3 trials.

The search for a COVID-19 vaccine will be the topic of a free MJH Life Sciences webinar at 6 p.m. Eastern Daylight Time on July 30.

As the US death toll from the coronavirus pandemic rises above 146,000 and more than 4 million Americans have tested positive for the virus, the country waits anxiously for approval of a vaccine that will begin to bring the virulent spread under control.

This race for a vaccine will be the topic of the one-hour session featuring experts on viruses and vaccines.

Click here to register for the free event

The panel for this webinar features:

  • Walter A. Orenstein, MD, professor of medicine, pediatrics, global health, and epidemiology at Emory University, and director of the Emory Vaccine Center; Orenstein spent 26 years with the US Immunization Program at the Center for Disease Control and Prevention. His research focuses on vaccine effectiveness and uptake.
  • Angela Rasmussen, PhD, is a virologist studying host responses to infection by combining classical virology with a modern systems biology approache. Her research focuses on identifying host response signatures predictive of infection severity or disease outcome and host pathways to target drug development or repurposing.
  • Gregory A. Poland, MD, studies the immunogenetics of vaccine response in adults and children. Along with his team within the Vaccine Research Group at the Mayo Clinic in Rochester, MN, his aim is to improve global health by pursuing challenges posed by infectious diseases and bioterrorism through clinical, laboratory, and epidemiologic vaccine search.